Barclays »

Zura Bio shares owned by Barclays

Quarter-by-quarter ownership of Zura Bio (ZURA) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Zura Bio

Tip: Access up to 7 years of quarterly data

All positions including Zura Bio held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zura Bio by Barclays

Quarter filed Position value Share count Share price at filing
2023-12-31 $110k 24k 4.66
2023-09-30 $15k 2.2k 6.80
2023-06-30 $13k 1.5k 8.62

More positions owned by Barclays

Invesco Qqq Tr Opt Call Option (QQQ)
SPDR S&ampP 500 ETF TR Opt Put Option (SPY)
Microsoft Corp Opt Call Option (MSFT)
Ishares Tr Opt Call Option (IWM)
Apple (AAPL)
Amazon Opt Call Option (AMZN)
Alphabet Opt Put Option (GOOGL)
NVIDIA Corporation (NVDA)
Tesla Opt Put Option (TSLA)
Meta Platforms Opt Put Option (META)
Ishares Tr Fund (HYG)
Alphabet Opt Call Option (GOOG)
Visa Opt Put Option (V)
Broadcom (AVGO)
Berkshire Hathaway (BRK.B)

View all positions for Barclays

Top funds holding Zura Bio

Dr. Jeffrey R. Jay, M.D.
Citadel Advisors
Vanguard Group
Calamos Advisors
Charles Schwab Investment Management
Raymond James & Associates
Hudson Bay Capital Management
Bank of New York Mellon
Two Sigma Investments
Bank of America Corporation
Alliancebernstein
Barclays
Occudo Quantitative Strategies
Goldman Sachs Group
Rhumbline Advisers

View all funds holding Zura Bio